Total Payments
$4,315
2024 Payments
$235.55
Companies
21
Transactions
73
Medicare Patients
1,392
Medicare Billing
$116,999
Payment Breakdown by Category
Food & Beverage$2,622 (60.8%)
Education$1,200 (27.8%)
Travel$492.67 (11.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,622 | 68 | 60.8% |
| Education | $1,200 | 1 | 27.8% |
| Travel and Lodging | $492.67 | 4 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $1,453 | 19 | $0 (2023) |
| Titan Surgical Group, LLC | $1,200 | 1 | $0 (2021) |
| Stryker Corporation | $689.82 | 11 | $0 (2019) |
| Onkos Surgical, Inc. | $117.70 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $107.02 | 6 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $105.87 | 5 | $0 (2024) |
| DePuy Synthes Sales Inc. | $96.17 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $75.83 | 5 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $73.66 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $67.71 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $235.55 | 8 | Onkos Surgical, Inc. ($117.70) |
| 2023 | $619.83 | 27 | Smith+Nephew, Inc. ($98.50) |
| 2022 | $102.16 | 4 | Smith+Nephew, Inc. ($70.87) |
| 2021 | $1,224 | 2 | Titan Surgical Group, LLC ($1,200) |
| 2020 | $16.09 | 1 | DePuy Synthes Sales Inc. ($16.09) |
| 2019 | $412.27 | 7 | Smith+Nephew, Inc. ($312.04) |
| 2018 | $953.58 | 15 | Stryker Corporation ($624.20) |
| 2017 | $751.35 | 9 | Smith & Nephew, Inc. ($686.09) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | Onkos Surgical, Inc. | ELEOS LIMB SALVAGE SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $117.70 | General |
| Category: Bone Implant | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 05/24/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC, PEAK | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Sports Early Intervention | ||||||
| 05/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Not Applicable | ||||||
| 03/22/2024 | CONMED Corporation | VISICLEAR (Device) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: GENERAL SURGERY | ||||||
| 03/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardio-renal | ||||||
| 01/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardio-renal | ||||||
| 12/12/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC, PEAK | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: Sports Early Intervention | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Not Applicable | ||||||
| 10/12/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $17.02 | General |
| 10/02/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Not Applicable | ||||||
| 09/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardio-renal | ||||||
| 09/19/2023 | Smith+Nephew, Inc. | REAL INTELLIGENCE (Device), JOURNEY II | Food and Beverage | In-kind items and services | $98.50 | General |
| Category: Recon Robotics | ||||||
| 09/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardio-renal | ||||||
| 08/08/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/03/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $30.16 | General |
| Category: Not Applicable | ||||||
| 05/31/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 359 | 415 | $72,910 | $26,745 |
| 2022 | 1 | 12 | 12 | $3,552 | $1,231 |
| 2021 | 11 | 355 | 470 | $80,224 | $18,585 |
| 2020 | 13 | 666 | 2,469 | $286,399 | $70,439 |
Total Patients
1,392
Total Services
3,366
Medicare Billing
$116,999
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 85 | 85 | $18,445 | $6,606 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $17,808 | $6,156 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 80 | $11,680 | $5,258 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 36 | $7,776 | $3,278 | 42.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 44 | 54 | $8,532 | $2,704 | 31.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $5,280 | $1,466 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 18 | $1,566 | $736.74 | 47.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 24 | 31 | $1,178 | $282.72 | 24.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 29 | 43 | $645.00 | $257.12 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $3,552 | $1,231 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 86 | $22,031 | $4,869 | 22.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 63 | 97 | $20,678 | $4,630 | 22.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 26 | $9,926 | $2,698 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 21 | $7,683 | $1,822 | 23.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $5,733 | $1,162 | 20.3% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 36 | 43 | $4,350 | $1,055 | 24.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 47 | 82 | $2,214 | $645.93 | 29.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 18 | $2,834 | $599.76 | 21.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 14 | 14 | $2,898 | $554.40 | 19.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 15 | 16 | $1,241 | $335.23 | 27.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 27 | 49 | $637.00 | $213.70 | 33.5% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2020 | 15 | 1,509 | $84,789 | $21,096 | 24.9% |
| 27447 | Repair of knee joint | Facility | 2020 | 12 | 12 | $53,808 | $12,487 | 23.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 113 | 213 | $45,639 | $10,621 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 129 | 195 | $40,755 | $9,945 | 24.4% |
About Dr. John Vani, MD
Dr. John Vani, MD is a Orthopaedic Surgery healthcare provider based in Moberly, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083727077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Vani, MD has received a total of $4,315 in payments from pharmaceutical and medical device companies, with $235.55 received in 2024. These payments were reported across 73 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,622).
As a Medicare-enrolled provider, Vani has provided services to 1,392 Medicare beneficiaries, totaling 3,366 services with total Medicare billing of $116,999. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Orthopaedic Surgery
- Other Specialties Sports Medicine
- Location Moberly, MO
- Active Since 08/16/2006
- Last Updated 03/16/2023
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1083727077
Products in Payments
- MAKO (Device) $594.28
- Anthology (Device) $384.96
- Journey II XR (Device) $261.45
- TRIGEN InterTAN (Device) $156.09
- Journey Uni (Device) $145.04
- REAL INTELLIGENCE (Device) $135.83
- Navio Surgical System (Device) $120.54
- ELEOS LIMB SALVAGE SYSTEM (Device) $117.70
- Arcalyst (Drug) $105.87
- PICO (Device) $100.68
- Kerendia (Drug) $90.37
- Quatro Link (Device) $73.66
- XARELTO (Drug) $67.71
- ORTHOVISC (Device) $65.70
- VISIONAIRE Cutting Guides (Device) $63.96
- ORENITRAM (Drug) $63.03
- VERQUVO (Drug) $58.81
- PICO Single Use Negative Pressure Wound Therapy (Device) $50.59
- Zilretta (Drug) $44.20
- T2 (Device) $39.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.